{"id":103803,"date":"2024-02-05T11:56:03","date_gmt":"2024-02-05T11:56:03","guid":{"rendered":"https:\/\/quixnet.net\/eli-lilly-results-blow-past-estimates-on-strong-zepbound-launch-surging-mounjaro-revenue-cnbc\/"},"modified":"2024-02-05T11:56:03","modified_gmt":"2024-02-05T11:56:03","slug":"eli-lilly-results-blow-past-estimates-on-strong-zepbound-launch-surging-mounjaro-revenue-cnbc","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/eli-lilly-results-blow-past-estimates-on-strong-zepbound-launch-surging-mounjaro-revenue-cnbc\/","title":{"rendered":"Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue &#8211; CNBC"},"content":{"rendered":"<div>\n<ol>\n<li><a target=\"_blank\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMiQ2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDIvMDYvZWxpLWxpbGx5LWxseS1lYXJuaW5ncy1xNC0yMDIzLmh0bWzSAUdodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyNC8wMi8wNi9lbGktbGlsbHktbGx5LWVhcm5pbmdzLXE0LTIwMjMuaHRtbA?oc=5\" rel=\"noopener\">Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue<\/a><font color=\"#6f6f6f\">CNBC<\/font><\/li>\n<li><a target=\"_blank\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMifGh0dHBzOi8vaW52ZXN0b3IubGlsbHkuY29tL25ld3MtcmVsZWFzZXMvbmV3cy1yZWxlYXNlLWRldGFpbHMvbGlsbHktcmVwb3J0cy1zdHJvbmctZm91cnRoLXF1YXJ0ZXItMjAyMy1maW5hbmNpYWwtcmVzdWx0cy1hbmTSAQA?oc=5\" rel=\"noopener\">Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and Company<\/a><font color=\"#6f6f6f\">Investors | Eli Lilly and Company<\/font><\/li>\n<li><a target=\"_blank\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMiSGh0dHBzOi8vd3d3LmJhcnJvbnMuY29tL2FydGljbGVzL2VsaS1saWxseS1lYXJuaW5ncy1zdG9jay1wcmljZS1mMjJjYWMwMdIBAA?oc=5\" rel=\"noopener\">Eli Lilly Stock Rises on Earnings Beat, Obesity Drug Sales<\/a><font color=\"#6f6f6f\">Barron&#8217;s<\/font><\/li>\n<li><a target=\"_blank\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50LzQwNzQ0MTI4LTQyM2MtNDRlOC1iMjJlLTUzYWE3YjA2NDMxNtIBAA?oc=5\" rel=\"noopener\">Live news: Eli Lilly says diabetes and obesity drugs will boost sales by 20% this year<\/a><font color=\"#6f6f6f\">Financial Times<\/font><\/li>\n<li><a target=\"_blank\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VsaS1saWxseS1tb3VudHMtY2xpbmljYWwtYW5kLWNvbW1lcmNpYWwtY2FzZS10aXJ6ZXBhdGlkZS1tb3VuamFyby16ZXBib3VuZC1jb21lLXRoZWlyLW93btIBAA?oc=5\" rel=\"noopener\">Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains<\/a><font color=\"#6f6f6f\">FiercePharma<\/font><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenueCNBC Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and CompanyInvestors | Eli Lilly and Company Eli Lilly Stock Rises on Earnings Beat, Obesity Drug SalesBarron&#8217;s Live news: Eli Lilly says diabetes and obesity drugs will boost [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[6],"tags":[],"class_list":{"0":"post-103803","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business","7":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/103803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=103803"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/103803\/revisions"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=103803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=103803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=103803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}